SE7708521L - Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan - Google Patents

Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan

Info

Publication number
SE7708521L
SE7708521L SE7708521A SE7708521A SE7708521L SE 7708521 L SE7708521 L SE 7708521L SE 7708521 A SE7708521 A SE 7708521A SE 7708521 A SE7708521 A SE 7708521A SE 7708521 L SE7708521 L SE 7708521L
Authority
SE
Sweden
Prior art keywords
cylfuran
aminoal
derivatives
procedure
preparation
Prior art date
Application number
SE7708521A
Other languages
Unknown language ( )
English (en)
Other versions
SE437373B (sv
Inventor
B J Price
J W Clitherow
J Bradshaw
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27448487&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE7708521(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB32465/76A external-priority patent/GB1565966A/en
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Priority claimed from KR7701808A external-priority patent/KR810000355B1/ko
Publication of SE7708521L publication Critical patent/SE7708521L/sv
Publication of SE437373B publication Critical patent/SE437373B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE7708521A 1976-08-04 1977-07-25 Forfarande for framstellning av ett aminoalkylfuranderivat med terapeutisk verkan SE437373B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB32465/76A GB1565966A (en) 1976-08-04 1976-08-04 Aminoalkyl furan derivatives
GB5068576 1976-12-06
GB2018777 1977-05-13
KR7701808A KR810000355B1 (ko) 1977-05-13 1977-08-04 아미노 알킬푸란 유도체의 제조방법

Publications (2)

Publication Number Publication Date
SE7708521L true SE7708521L (sv) 1978-02-05
SE437373B SE437373B (sv) 1985-02-25

Family

ID=27448487

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7708521A SE437373B (sv) 1976-08-04 1977-07-25 Forfarande for framstellning av ett aminoalkylfuranderivat med terapeutisk verkan
SE8205533A SE454882B (sv) 1976-08-04 1982-09-28 Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan
SE8206556A SE454883B (sv) 1976-08-04 1982-11-17 Aminoalkylfuranderivat till anvendning som mellanprodukter vid framstellning av aminoalkylfuranderivat med terapeutisk verkan

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE8205533A SE454882B (sv) 1976-08-04 1982-09-28 Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan
SE8206556A SE454883B (sv) 1976-08-04 1982-11-17 Aminoalkylfuranderivat till anvendning som mellanprodukter vid framstellning av aminoalkylfuranderivat med terapeutisk verkan

Country Status (16)

Country Link
AT (1) AT375931B (sv)
CH (2) CH642072A5 (sv)
CY (1) CY1077A (sv)
DE (2) DE2760097C2 (sv)
DK (2) DK148258C (sv)
ES (2) ES461334A1 (sv)
FI (1) FI72318C (sv)
HK (1) HK55780A (sv)
IE (1) IE45456B1 (sv)
IT (2) IT1126759B (sv)
KE (1) KE3080A (sv)
NZ (2) NZ184759A (sv)
PH (1) PH13540A (sv)
PT (1) PT66874B (sv)
SE (3) SE437373B (sv)
YU (2) YU40006B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203909A (en) * 1978-09-26 1980-05-20 Bristol-Myers Company Furan compounds
YU52598A (sh) * 1998-11-19 2001-05-28 D.D. Zdravlje- sektor za istraživanje i razvoj POSTUPAK ZA sintezu N-[2[[[5=[(DIALKILAMINO)METIL]-2= FURANIL]METIL]TIO]ETIL]-N'-ALKIL-2-NITRO 1,1 ALKENDIAMINA I NJIHOVIH HIDROHLORIDA

Also Published As

Publication number Publication date
PH13540A (en) 1980-06-26
PT66874B (en) 1979-01-23
DK416384D0 (da) 1984-08-30
PT66874A (en) 1977-09-01
CH641176A5 (en) 1984-02-15
DK337977A (da) 1978-02-05
SE8206556L (sv) 1982-11-17
IE45456B1 (en) 1982-08-25
NZ184759A (en) 1980-09-12
SE8205533D0 (sv) 1982-09-28
IE45456L (en) 1978-02-04
SE8206556D0 (sv) 1982-11-17
DK148258C (da) 1985-10-14
SE8205533L (sv) 1982-09-28
CH642072A5 (en) 1984-03-30
YU191177A (en) 1983-01-21
FI72318C (sv) 1987-05-11
YU40088B (en) 1985-06-30
SE454882B (sv) 1988-06-06
CY1077A (en) 1980-12-27
IT1126759B (it) 1986-05-21
IT1221058B (it) 1990-06-21
IT8548437A0 (it) 1985-08-01
SE437373B (sv) 1985-02-25
DK149952C (da) 1987-07-06
KE3080A (en) 1980-10-03
DE2759959C2 (sv) 1988-08-04
FI772264A (sv) 1978-02-05
DE2760097C2 (sv) 1989-08-17
NZ191383A (en) 1980-09-12
FI72318B (fi) 1987-01-30
AT375931B (de) 1984-09-25
SE454883B (sv) 1988-06-06
DK148258B (da) 1985-05-20
ES461334A1 (es) 1979-05-16
DK149952B (da) 1986-11-03
ATA574077A (de) 1984-02-15
YU200082A (en) 1983-01-21
ES470836A1 (es) 1979-02-16
HK55780A (en) 1980-10-10
DK416384A (da) 1984-08-30
YU40006B (en) 1985-06-30

Similar Documents

Publication Publication Date Title
SE434395B (sv) Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkan
SE7805590L (sv) Forfarande for framstellning av aminoalkylderivat med farmaceutisk verkan
SE435059B (sv) Forfarande for framstellning av med kveveheterocykliska grupper substituerade 1-fenyl-2-alkylaminoetanol-foreningar
SE7805591L (sv) Forfarande for framstellning av aminoalkylbensen-derivat med farmaceutisk verkan
NO821848L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE429338B (sv) Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan
SE7701379L (sv) Forfarande for framstellning av bensendimetanolderivat med farmakologisk verkan
SE411671B (sv) Forfarande for framstellning av tripeptidderivat med terapeutisk verkan
SE7804736L (sv) Forfarande for framstellning av isoindolinderivat med terapeutisk verkan
SE434263B (sv) Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan
SE440907B (sv) Forfarande for framstellning av imidazolderivat med farmaceutisk verkan
SE7703721L (sv) Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan
SE7800930L (sv) Forfarande for framstellning av bensensulfonamid- och bensenkarboxamidderivat med terapeutisk verkan
SE7600343L (sv) Forfarande for framstellning av ferrocenderivat med terapeutisk verkan
SE7608538L (sv) Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan
SE7608115L (sv) Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan
SE7805105L (sv) Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan
SE7708521L (sv) Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan
SE7712219L (sv) Forfarande for framstellning av trans-5a-aryl-dekahydrobenzazpiner med terapeutisk verkan
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE7713839L (sv) Forfarande for framstellning av indanderivat med terapeutisk verkan
SE7606236L (sv) Forfarande for framstellning av piperazinforeningar med terapeutisk verkan
SE417712B (sv) Forfarande for framstellning av n-(6-acyloxibensotiazol-2-yl)-nŸ-fenylkarbamider med terapeutisk verkan
SE7712217L (sv) Forfarande for framstellning av dekahydrocyklopent-(c)azepiner med terapeutisk verkan

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7708521-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7708521-5

Format of ref document f/p: F